Testimony from the Bedside: From Coley's Toxins to Targeted Immunotherapy
Authors:
- David E. FisherDFDavid E. Fisher
- 1 July 2010
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 18 (1) , 9-10
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunityProceedings of the National Academy of Sciences, 2010
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodiesJournal of Experimental Medicine, 2009
- Anti–Cytotoxic T-Lymphocyte Antigen-4 Antibody: The First in an Emerging Class of Immunomodulatory Antibodies for Cancer TreatmentJournal of Clinical Oncology, 2008
- CTLA-4 Control over Foxp3 + Regulatory T Cell FunctionScience, 2008
- A MOLECULAR PERSPECTIVE OF CTLA-4 FUNCTIONAnnual Review of Immunology, 2006
- Enhancement of Antitumor Immunity by CTLA-4 BlockadeScience, 1996
- THE TREATMENT OF MALIGNAT TUMORS BY REPEATED INOCULATIONS OF ERYSIPELASThe American Journal of the Medical Sciences, 1893